| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
1 Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, Minnesota; 2 Division of Epidemiology, School of Public Health, University of Minnesota, Minneapolis, Minnesota; and 3 Department of Nutrition, University of Oslo, Oslo, Norway
Requests for reprints: Paul J. Limburg, Division of Epidemiology, University of Minnesota, 1300 South Second Street, Suite 300, Minneapolis, MN 55454. Phone: 507-266-4338; Fax: 507-266-0350. E-mail limburg.paul{at}mayo.edu.
Objective: Controversy remains regarding the association between type 2 diabetes mellitus (DM) and colorectal cancer (CRC) risk. To clarify and extend the existing data, we prospectively evaluated the association between self-reported type 2 DM (onset at >30 years of age) and incident CRC, overall and by anatomic subsite, among postmenopausal women in the Iowa Women's Health Study (n = 35,230).
Methods: After 14 years of follow-up, a total of 870 incident CRC cases were identified through annual linkage to the Iowa Cancer Registry. DM was analyzed as reported at baseline and as a time-dependent variable using information obtained during follow-up. CRC risks were estimated using Cox proportional hazards regression models.
Results: After adjusting for age, body mass index and other potential confounding variables, the relative risk (RR) for women with DM versus women without DM was modestly increased at 1.4 [95% confidence interval (95% CI), 1.1-1.8]. By anatomic subsite, the RR for proximal colon cancer was statistically significantly increased (RR, 1.9; 95% CI, 1.3-2.6), whereas the RRs for distal colon (RR, 1.1; 95% CI, 0.6-1.8) and rectal cancer (RR, 0.8; 95% CI, 0.4-1.6) were not statistically different from unity. Analyses that included DM ascertained at baseline and follow-up yielded similar results.
Conclusion: In this large, prospective study of postmenopausal women, the association between DM and incident CRC was found to be subsite specific. If confirmed by others, this finding implies that CRC prevention strategies among type 2 DM patients should include examination of the proximal colon.
Key Words: colorectal neoplasms • diabetes mellitus • cohort study • postmenopause • obesity • Gastrointestinal cancers: colorectal • Reproductive, hormonal, and related risk factors • Descriptive, Risk Factor, and Methodological Studies
This article has been cited by other articles:
|
|
 |
|
  K. N. Ealey, S. Lu, D. Lau, and M. C. Archer Reduced susceptibility of muscle-specific insulin receptor knockout mice to colon carcinogenesis Am J Physiol Gastrointest Liver Physiol, March 1, 2008; 294(3): G679 - G686. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. H. Kim, Y. J. Lim, Y.-H. Kim, I.-K. Sung, S. G. Shim, S.-O. Oh, S.-S. Park, S. Yang, H. J. Son, P.-L. Rhee, et al. Is Metabolic Syndrome A Risk Factor for Colorectal Adenoma? Cancer Epidemiol. Biomarkers Prev., August 1, 2007; 16(8): 1543 - 1546. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Sturmer, J. E. Buring, I-M. Lee, J. M. Gaziano, and R. J. Glynn Metabolic Abnormalities and Risk for Colorectal Cancer in the Physicians' Health Study Cancer Epidemiol. Biomarkers Prev., December 1, 2006; 15(12): 2391 - 2397. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Flood, U. Peters, D. J. Jenkins, N. Chatterjee, A. F Subar, T. R Church, R. Bresalier, J. L Weissfeld, R. B Hayes, A. Schatzkin, et al. Carbohydrate, glycemic index, and glycemic load and colorectal adenomas in the Prostate, Lung, Colorectal, and Ovarian Screening Study. Am. J. Clinical Nutrition, November 1, 2006; 84(5): 1184 - 1192. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Lin, N. R. Cook, I-M. Lee, J. E. Manson, J. E. Buring, and S. M. Zhang Total magnesium intake and colorectal cancer incidence in women. Cancer Epidemiol. Biomarkers Prev., October 1, 2006; 15(10): 2006 - 2009. [Full Text] [PDF]
|
|
|
|
 |
|
 K. Bowers, D. Albanes, P. Limburg, P. Pietinen, P. R. Taylor, J. Virtamo, and R. Stolzenberg-Solomon A Prospective Study of Anthropometric and Clinical Measurements Associated with Insulin Resistance Syndrome and Colorectal Cancer in Male Smokers Am. J. Epidemiol., October 1, 2006; 164(7): 652 - 664. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Inoue, M. Iwasaki, T. Otani, S. Sasazuki, M. Noda, S. Tsugane, and for the Japan Public Health Center-Based Prospecti Diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan. Arch Intern Med, September 25, 2006; 166(17): 1871 - 1877. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Irby, W. F. Anderson, D. E. Henson, and S. S. Devesa Emerging and widening colorectal carcinoma disparities between blacks and whites in the United States (1975-2002). Cancer Epidemiol. Biomarkers Prev., April 1, 2006; 15(4): 792 - 797. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. R. Folsom and C.-P. Hong Magnesium Intake and Reduced Risk of Colon Cancer in a Prospective Study of Women Am. J. Epidemiol., February 1, 2006; 163(3): 232 - 235. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. C. Larsson, N. Orsini, and A. Wolk Diabetes Mellitus and Risk of Colorectal Cancer: A Meta-Analysis J Natl Cancer Inst, November 16, 2005; 97(22): 1679 - 1687. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Tavani, F. Bravi, C. Bosetti, S. Franceschi, F. Levi, R. Talamini, and C. La Vecchia Diabetes Mellitus and Subsite-Specific Colorectal Cancer Risks in the Iowa Women's Health Study Cancer Epidemiol. Biomarkers Prev., September 1, 2005; 14(9): 2277 - 2277. [Full Text] [PDF]
|
|
|
|
 |
|
 S. C. Larsson, E. Giovannucci, and A. Wolk Diabetes and Colorectal Cancer Incidence in the Cohort of Swedish Men Diabetes Care, July 1, 2005; 28(7): 1805 - 1807. [Full Text] [PDF]
|
|
|
|
|
|
E. Lim, I.T. Jones, P. Gibbs, S. McLaughlan, I. Faragher, I. Skinner, M.W. Chao, and J. Johns Subsite-Specific Colorectal Cancer in Diabetic and Nondiabetic Patients Cancer Epidemiol. Biomarkers Prev., June 1, 2005; 14(6): 1579 - 1582. [Full Text] [PDF]
|
|
|
|
 |
|
 A. G Renehan and S. M Shalet Diabetes, insulin therapy, and colorectal cancer BMJ, March 12, 2005; 330(7491): 551 - 552. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
